BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 692273)

  • 1. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptor binding regulated by guanine nucleotides.
    Creese I; Usdin TB; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanyl nucleotides decrease antagonist binding at high affinity dopamine receptors.
    Andorn AC; Kohagen KR
    Eur J Pharmacol; 1984 Aug; 103(1-2):127-31. PubMed ID: 6479225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Eur J Pharmacol; 1980 May; 63(2-3):217-22. PubMed ID: 6155277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of guanine nucleotides on striatal dopamine receptors.
    Zahniser NR; Molinoff PB
    Nature; 1978 Oct; 275(5679):453-5. PubMed ID: 692725
    [No Abstract]   [Full Text] [Related]  

  • 8. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
    Hirschhorn ID; Makman MH; Gardner EL
    Eur J Pharmacol; 1980 Mar; 62(1):123-4. PubMed ID: 6154585
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatum.
    Kayaalp SO; Neff NH
    Life Sci; 1980 Jun; 26(22):1837-41. PubMed ID: 7401904
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 12. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides.
    Kilpatrick BF; De Lean A; Caron MG
    Mol Pharmacol; 1982 Sep; 22(2):298-303. PubMed ID: 7144731
    [No Abstract]   [Full Text] [Related]  

  • 14. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadate inhibits agonist binding to D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Mol Neurosci; 1991; 3(1):1-6. PubMed ID: 1679343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors.
    Urwyler S
    J Neurochem; 1987 Nov; 49(5):1415-20. PubMed ID: 2959751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ADTN to define specific 3H-spirerone binding to receptors in brain.
    Quik M; Iversen LL; Larder A; Mackay AV
    Nature; 1978 Aug; 274(5670):513-4. PubMed ID: 672981
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
    De Lean A; Kilpatrick BF; Caron MG
    Mol Pharmacol; 1982 Sep; 22(2):290-7. PubMed ID: 7144730
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ; Horowitz SG; Dvorkin B; Makman MH
    Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.